Dr. James Elliott Bradner MD Hematologist

Dr. James Bradner is a hematologist in Boston, Massachusetts. He is affiliated with multiple hospitals in the area, including Boston Children's Hospital and Brigham and Women's Faulkner Hospital. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice for 15 years. He is one of 49 doctors at Boston Children's Hospital and one of 17 at Brigham and Women's Faulkner Hospital who specialize in Hematology.

Are you Dr. James Bradner? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Education & Medical Training

Brigham and Women's Hospital
Residency, Internal Medicine, 1999 - 2002

Brigham and Women's Hospital
Fellowship, Hematology/Oncology, 2002 - 2005

University of Chicago Pritzker School of Medicine
Class of 1999

Certifications & Licensure

American Board of Internal Medicine
Certified in Cardiovascular Disease

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Interventional Cardiology

WI State Medical License
Active through 2013

Awards, Honors & Recognition

Elected Member, The American Society for Clinical Investigation
2011

Publications & Presentations

An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.
Knoechel, B.,Roderick, J. E.,Williamson, K. E.,Zhu, J.,Lohr, J. G.,Cotton, M. J.,Gillespie, S. M.,Fernandez, D.,Ku, M.,Wang, H.,Piccioni, F.,Silver, S. J.,Jain, M.,Pearson, D.,Kluk, M. J.,Ott, C. J.,Shultz, L. D.,Brehm, M. A.,Greiner, D. L.,Gutierrez, A.,Stegmaier, K.,Kung, A. L.,Root, D. E.,Bradner, J. E.,Aster, J. C.,Kelliher, M. A.,Bernstein, B. E.

RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten-Mutant Metastasis.
Cho, H.,Herzka, T.,Zheng, W.,Qi, J.,Wilkinson, J. E.,Bradner, J. E.,Robinson, B. D.,Castillo-Martin, M.,Cordon-Cardo, C.,Trotman, L. C.

Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia.
Reynolds, C.,Roderick, J. E.,Labelle, J. L.,Bird, G.,Mathieu, R.,Bodaar, K.,Colon, D.,Pyati, U.,Stevenson, K. E.,Qi, J.,Harris, M.,Silverman, L. B.,Sallan, S. E.,Bradner, J. E.,Neuberg, D. S.,Look, A. T.,Walensky, L. D.,Kelliher, M. A.,Gutierrez, A.

See all 57 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Massachusetts Blue Care Elect PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Tufts Health Plan PPO
  • UniCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.